Glioblastoma
FDA Approves Temodar (Temozolomide) Label Updates for Anaplastic Astrocytoma Treatment
Anika Sharma
In a significant development, the FDA has granted approval for temozolomide (marketed as Temodar) to be used as adjuvant therapy ...
ABM-1310 receives Orphan Drug Designation from the FDA for Glioblastoma
SG Tylor
Source – ABM Therapeutics ABM Therapeutics has received orphan drug designation from the FDA for ABM-1310, a novel small molecule ...
